• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Doxorubicin: Biosynthesis, Clinical Uses & Health Implications

Doxorubicin: Biosynthesis, Clinical Uses & Health Implications

9781631172335
573.24 zł
515.91 zł Save 57.33 zł Tax included
Lowest price within 30 days before promotion: 515.91 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Doxorubicin is a classical but useful anti-tumour agent. It is used for the treatment of a variety of malignancies including solid tumours and leukaemia due to its broad spectrum anti-tumour activity. It also has well known toxic side effects that must be minimised for its successful use clinically. This book discusses intraperitoneal doxorubicin; preclinical characterisation of the drug-delivery device DCBeads for transarterial chemoembolisation of doxorubicin and nemorubicin; doxorubicin-induced cardiomyopathy; advanced therapies of doxorubicin by carrier of drug delivery system or combined food components; and prevention and management of cariotoxicity.
Product Details
74503
9781631172335
9781631172335

Data sheet

Publication date
2014
Issue number
1
Cover
hard cover
Pages count
143
Dimensions (mm)
155.00 x 230.00
Weight (g)
394
  • Preface; Intraperitoneal Doxorubicin:: Rationale, Pharmacokinetic Studies, & Clinical Results; Preclinical Characterization of the Drug-Delivery Device DCBeads for Transarterial Chemoembolization of Doxorubicin & Nemorubicin, a Methoxy-Morpholinyl Derivative; Doxorubicin-Induced Cardiomyopathy; Advanced Therapies of Doxorubicin by Carrier of Drug Delivery System or Combined Food Components; Prevention & Management of Cardiotoxicity, Nausea & Vomiting in Doxorubicin-Treated Breast Cancer Patients; Index.
Comments (0)